Vanguard High Dividend Yield ETF
Most Recent
Basic MaterialsA Look at Analysts’ Top 5 US Steel Stocks
In this overview article, we’ll see how analysts are rating the leading steel stocks, and we’ll also compare performance from the top five steel companies.
Real EstateExtra Space Storage: What’s Driving the Dividend and Valuations?
In the first quarter, Extra Space Storage’s (EXR) revenue grew 9%, driven by property rental, tenant reinsurance, and management fees.
Company & Industry OverviewsJohnson & Johnson Advances in Robotics Surgery with Orthotaxy
On February 20, Johnson & Johnson (JNJ) announced the acquisition of Orthotaxy to develop its robot-assisted orthopedics surgery platform.
Energy & UtilitiesWhat Will Drive The Dividend Growth Of ETR?
What is the dividend outlook? Entergy Corporation’s (ETR) present dividend yield of 4.6% has been driven by dividend growth and price loss. Dividends grew 2% each in 2016 and 2017. The dividend is projected to grow 2% in 2018. What is the projected dividend payout? The company recorded a dividend payout of 48% in 2016. […]
HealthcareWhat Will Drive Amgen’s Dividends?
Amgen (AMGN) has five-year dividend growth of 26%.
Company & Industry OverviewsJ&J Accelerates Near-Term Goals in Medical Device Business
Johnson & Johnson has launched a number of key products and has entered into some strategic partnerships and collaborations that have helped the company accelerate the growth of its medical device business.
Company & Industry OverviewsGilead Sciences on the Street in January: Analyst Recommendations
In December 2017, Gilead Sciences (GILD) and its subsidiary specialized in cell therapy, Kite, entered into an agreement with Cell Design Labs.
Company & Industry OverviewsOpdivo Could Be Long-Term Growth Driver for Bristol-Myers Squibb
In 1Q17, 2Q17, and 3Q17, Opdivo reported revenues of $1.1 billion, $1.2 billion, and $1.3 billion, respectively.
HealthcareThese Factors Are Contributing to Gilead Sciences’ Weak Outlook
Gilead Sciences’ (GILD) revenue fell 7% and 13% in 2016 and 9M17, respectively. The fall was due to lower product sales. Both antiviral products and other products recorded declines in both the periods.
Company & Industry OverviewsHow Increasing Biologic Penetration Could Boost AbbVie’s Revenues
AbbVie (ABBV) is currently focused on advancing the research programs for its late-stage immunology assets, Upadacitinib and Risankizumab.
Tech & Comm ServicesHow Does GOOGL Compare to Broad Indexes?
Alphabet’s (GOOGL) revenue rose 20% and 22% in 2016 and 9M17 (the first nine months of 2017), respectively.
Company & Industry OverviewsHow Has Eli Lilly’s Cyramza Performed
In 3Q17, Eli Lilly’s (LLY) Cyramza generated revenues of $196 million, which reflected ~23% growth on a YoY basis and 5% growth on a quarter-over-quarter basis.
Company & Industry OverviewsWhat Analysts Recommend for Bristol-Myers Squibb in November 2017
23 analysts were tracking Bristol-Myers Squibb in November 2017. Six of them recommended a “strong buy” rating, while four recommended a “buy.”
Energy & UtilitiesHow the Dividend Cut Affected KMI’s Dividend Yield
Kinder Morgan’s (KMI) costs and expenses rose 2.0% in 2015 before falling 21.0% in 2016.
ConsumerA Look at Nordstrom’s Dividend Yield Trajectory
Nordstrom’s (JWN) net sales rose 8% and 3% in 2015 and 2016, respectively.
IndustrialsHow Have Price Gains Impacted RTN’s Dividend Yield?
Raytheon Company (RTN) is a technology and innovation frontrunner that focuses on worldwide defense and other government markets.
Tech & Comm ServicesWhy the Dividend Yield of Microsoft Has Taken a Downturn
Microsoft’s (MSFT) 5.0% revenue growth in 2017 has been mainly driven by productivity and business processes and intelligent cloud, offset by more personal computing and other segments.
Tech & Comm ServicesFrontier Communications: High Dividend Yield despite Dividend Cut
In this series, we’ll look some small-cap stocks with high dividend yields.
Company & Industry OverviewsAnalysts’ Recommendations for Pfizer in August 2017
Of the 22 analysts covering Pfizer (PFE) in August 2017, one analyst recommended a “strong buy” and ten analysts recommended a “buy.” On August 26, Pfizer had a consensus 12-month target price of $37.45 for a 12.7% return on investment.
Company & Industry OverviewsMerck’s Hospital Acute Care Business: A Post-2Q17 Update
In 2Q17, Merck’s (MRK) Bridion generated revenues of ~$163 million, which reflected ~44% growth on a year-over-year basis and 10% growth on a quarter-over-quarter basis.
Basic MaterialsDividend Yield of Air Products & Chemicals
In this series, we’ll be looking at ten dividend aristocrats with low PE ratios. Dividend aristocrats are S&P 500 stocks that have raised their dividend payouts for at least 25 successive years.
ConsumerA Brief Look at Dividend Aristocrats
The S&P 500 Dividend Aristocrat Index is made up of 51 S&P 500 (SPY) (SPX-INDEX) companies that have increased their dividends for 25 successive years.
Company & Industry OverviewsGauging Amgen’s Xgeva Contribution in 2017
Xgeva revenue trends In 2Q17, Amgen’s (AMGN) Xgeva generated revenues of ~$395 million, which reflected ~4% growth on a YoY (year-over-year) basis and a 2% decline on a QoQ (quarter-over-quarter) basis. In 2Q17, in the US, Xgeva generated revenues of ~$292 million, which reflected ~6% YoY growth and a ~2% QoQ decline. Outside the US, […]
IndustrialsAnalyzing the Dividend Curves of General Electric and Cisco Systems
General Electric’s (GE) revenue fell 7.0% in the first half of 2017, driven by its energy connections and lighting business.
FinancialsAmerican Capital Agency: A 5-Year Slump in Funds from Operations
American Capital Agency (AGNC) paid 134.5% of its earnings as dividends in 2016 compared to 257.1% in 1Q17.
MiscellaneousA Look a the Top Twenty Dividend Growers over the Last 25 Years
This series will discuss how these stocks have been able to achieve continuous dividend growth.
Company & Industry OverviewsInside BMY’s Yervoy: What the Revenue Trends Tell Us
In 2016, Bristol-Myers Squibb’s (BMY) Yervoy reported revenues of ~$1.1 billion, which represents a ~6% YoY rise.
MiscellaneousAnalyzing the Dividend Yields of the Cyclical and Defensive Sectors
The S&P 500 (SPY) defensive sectors tend to offer an attractive yield to investors during low-interest environments or when the economy is slowing down.
Company & Industry OverviewsWhy Viekira Could Witness a Modest Revenue Fall in 2017
In 2016, AbbVie’s (ABBV) Viekira generated revenue of ~$1.5 billion, a fall of ~7% year-over-year (or YoY). In 1Q17, the drug reported revenue of ~$236 million.
Company & Industry OverviewsNplate and Vectibix Could Contribute to Amgen’s Revenue Growth in 2017
In 1Q17, Amgen’s (AMGN) Nplate generated revenues of ~$154 million, which reflected a year-over-year growth rate of 9%.
Company & Industry OverviewsHow Has VLO’s Dividend Yield Shaped Up?
Valero Energy (VLO) has consistently delivered returns to shareholders in the form of dividends.
Company & Industry OverviewsBP’s Dividend Yield: What You Need to Know
BP (BP) has consistently given returns to shareholders in the form of dividends. We have evaluated the company’s dividend yield.
Company & Industry OverviewsA Look at Patterson-UTI Energy’s Segment Drivers
From 4Q15 to 4Q16, Patterson-UTI Energy’s (PTEN) Contract Drilling segment’s revenue fell ~33.0%.
Company & Industry OverviewsIs National Oilwell Varco’s North America Onshore Improving?
From 4Q15 to 4Q16, revenues for National Oilwell Varco’s (NOV) Rig Systems segment fell ~58%. This was the highest revenue drop among NOV’s operating segments.
Earnings ReportWhat Drove Patterson-UTI Energy’s Performance in 4Q16?
In 2016, Patterson-UTI Energy (PTEN) recorded $915.8 million in revenues—52% lower compared to 2015. In 2016, the company’s net loss was $318.6 million.
Company & Industry OverviewsGeneral Electric Is Eyeing a Big Slice of the Software Pie
On January 10, 2017, General Electric (GE) completed its acquisition of ServiceMax, a leader in cloud-based field service management solutions, for $915.0 million.
Company & Industry OverviewsZepatier Should Boost Merck’s Profit Margins in the Future
On January 28, Merck’s Zepatier secured approval from the FDA as a therapy for adult patients suffering from genotype 1 or genotype 4 HCV (Hepatitis C).
Company & Industry OverviewsWhat Is Chevron’s Cash Flow Strategy?
In the first nine months of 2016, CVX’s cash flow from operations stood at $8.9 billion, falling from $14.9 billion in the first nine months of 2015.
Company & Industry OverviewsHow Has BP’s Dividend Yield Shaped Up?
BP’s (BP) dividend yield rose from 5.6% in 3Q13 to 7.7% in 3Q16.
Company & Industry OverviewsWhat Does Phillips 66’s Cash Flow Analysis Suggest?
Phillips 66’s cash balance fell 52% to ~$2.3 billion in 3Q16 due to cash inflow from operations, offset by weak cash outflow from financing and investing.
Company & Industry OverviewsBernstein: Excess Risk Aversion Has Made Investors ‘Wallflowers’
In his November Insights newsletter, Richard Bernstein stated, “It is incredible that investors have basically been wallflowers during the second longest bull market of the post-war period.”
Company & Industry OverviewsPfizer Makes Progress with Its 2016 Immuno-Oncology Programs
Including various combination therapies, Pfizer is actively involved in 30 research programs in the immuno-oncology space.
Company & Industry OverviewsWhat Could Drive National Oilwell Varco’s Growth?
From 3Q15 to 3Q16, National Oilwell Varco’s Rig Systems segment’s revenue fell ~69%—the highest revenue fall among the company’s operating segments.
Earnings ReportHow Did National Oilwell Varco’s Segments Perform in 3Q16?
Between 3Q15 and 3Q16, National Oilwell Varco’s (NOV) Rig Systems segment revenue fell ~69%.
Earnings ReportWhy the Oil and Gas business Was GE’s Achilles Heel in 3Q16
General Electric’s Oil and Gas segment’s revenue fell to 25% in 3Q16 to $2.9 billion, while the segment’s profit fell 42% in 3Q16.
Earnings ReportWhat Are Wall Street Analysts’ Forecasts for PTEN?
Approximately 55% of the analysts tracking Patterson-UTI Energy rated it as a “buy,” ~26% rated it as a “hold,” and the other 19% rated it as a “sell.”
Earnings ReportExxonMobil’s Stock Performance ahead of Its 3Q16 Earnings
ExxonMobil’s (XOM) stock fell 19% from October 14, 2014, to January 20, 2016, due to a fall in crude oil prices. Since then the stock has recovered.
Company & Industry OverviewsHow Are Petrobras’s Cash Flows Positioned?
In 1H16, Petrobras’s (PBR) cash flow from operations stood at $10.7 billion, falling from $13 billion in 1H15 due to a fall in oil prices.
Company & Industry OverviewsBank of America Merrill Lynch Upgrades Domtar to ‘Neutral’
Domtar’s (UFS) net income and earnings per share fell to $18.0 million and $0.29, respectively, in 2Q16, compared with $38.0 million and $0.60, respectively, in 2Q15.
Company & Industry OverviewsIs Delek’s Shareholder Yield Rising?
Delek US Holdings’ (DK) cash balance remained flat year-over-year at $377 million in 2Q16.
Company & Industry OverviewsWhy Is Domtar Planning to Use Fluff Pulp in Manufacturing?
Price movement Domtar (UFS) has a market cap of $2.3 billion. It fell 1.4% to close at $36.97 per share on September 23, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were 4.5%, -1.2%, and 2.3%, respectively, on the same day. UFS is trading 0.49% above its 20-day moving average, 0.73% below […]
Company & Industry OverviewsHow Are Shell’s Cash Flows Positioned?
In 1H16, Shell generated around $2.9 billion in cash from operations. It had cash outflows of $11.1 billion in the form of capex and $4.7 billion in the form of dividends.
Company & Industry OverviewsWhat Do Chevron’s Institutional Holdings Suggest?
Chevron’s (CVX) institutional holdings currently stand at ~70%. The level of these holdings shows the confidence level, or sentiment, that sophisticated market participants like institutions have in the stock.
Company & Industry OverviewsEnergy Stocks’ Historical Averages in Focus
In 2Q16, ExxonMobil (XOM), Chevron (CVX), and Royal Dutch Shell (RDS.A) traded at EV-to-EBITDA multiples above their historical averages.
Basic MaterialsDomtar Acquires Home Delivery Incontinent Supplies
Domtar has a market cap of $2.5 billion. It rose by 0.60% and closed at $38.45 per share on August 18. It reported 2Q16 consolidated sales of $1.27 billion.
Company & Industry OverviewsWhat Does BP’s Short Interest Analysis Reveal?
Short interest in BP (BP), which has been rising since the beginning of 2016, has witnessed a 23% fall since July 14, 2016.
Earnings ReportHow Did Petrobras’s Stock Perform on Its Earnings Day?
Petrobras announced its earnings on August 11, 2016, after the Market closed. On that day, PBR’s stock opened at $8.47 per share.
Basic MaterialsDomtar Declares a Dividend of $0.42 Per Share
Domtar (UFS) fell by 0.38% to close at $39.22 per share during the first week of August 2016.
Earnings ReportDid Tesoro’s 2Q16 Earnings Meet Expectations?
Tesoro (TSO) posted 2Q16 revenues of $6.3 billion, which surpassed Wall Street analyst estimates.
Basic MaterialsWhy Did Dow’s Consumer Solutions Segment’s Revenue Rise in 2Q16?
The Consumer Solutions segment is Dow Chemical’s lowest revenue generator. In 2Q16, the segment reported revenue of $1.3 billion.
Earnings ReportHow Shell’s Stock Performed after Its 2Q16 Earnings Release
Royal Dutch Shell (RDS.A) announced lower-than-expected earnings on July 28, 2016, before the markets opened.
Basic MaterialsHow Did Domtar Perform in 2Q16?
Domtar (UFS) has a market cap of $2.5 billion. It rose by 11.9% to close at $39.53 per share on July 27, 2016.
Basic MaterialsCan LyondellBasell Continue to Raise Net Profit Margin in 2Q16?
As of July 19, analysts are expecting LyondellBasell’s (LYB) net profit margins to be ~14.6% in 2Q16 as compared to 14.5% in 2Q15 and 14.1% in 1Q16.
Earnings ReportWall Street Analysts’ Forecast for NOV before Its 2Q16 Earnings
Approximately 23% of analysts tracking NOV rated it as a “buy” or some equivalent. Approximately 64% rated the company as a “hold” or some equivalent.
Company & Industry OverviewsIs Patterson-UTI Energy Meeting Its Fund Obligations Internally?
Patterson-UTI Energy’s (PTEN) internal cash generation has not been adequate to cover its external obligations.
Company & Industry OverviewsWhat Does Total’s Cash Flow Analysis Suggest?
In 1Q16, Total’s (TOT) cash flow from operations stood at $1.9 billion, around 57% lower than 1Q15. TOT’s cash outflow from investing stood at $3.9 billion in 1Q16 compared to $5.9 billion in 1Q15.
Company & Industry OverviewsRichard Bernstein: Markets React to Better or Worse
While discussing his views on the corporate profit cycle in the US with CNBC’s Michael Santoli, Richard Bernstein provided an interesting insight: The Market does not react to the absolutes of good or bad—it’s always better or worse.
Company & Industry OverviewsWhy BP’s Leverage Ratio Is Trending Higher
BP’s net debt-to-adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) stood at 1.7x in 1Q16.
Company & Industry OverviewsWhat Does Tesoro’s Cash Flow Analysis Suggest?
With the fall in refining earnings in the past couple of quarters, Tesoro’s cash flow from operations fell to $184 million in 1Q16.
Earnings ReportA Segmental Analysis of Petrobas before 1Q16 Earnings
Sinking oil prices have changed segment dynamics considerably for Petrobras (PBR). Its Exploration & Production segment reported a loss in 4Q15 due to impairments and lower crude oil prices.
Earnings ReportUnderstanding Tesoro’s 1Q16 Earnings versus Expectations
Tesoro posted its 1Q16 earnings on May 4, reporting revenues of $5.1 billion, which missed analyst estimates. Its adjusted EPS stood at $1.2.
Company & Industry OverviewsDo Eni’s Stock and Oil and Natural Gas Prices Correlate?
Eni is insulated to a certain extent from oil price volatility due to its integrated model. However, the company is not immune to changes in oil prices.
Company & Industry OverviewsBehind Helmerich & Payne’s Value Drivers in Fiscal 2Q16
Helmerich & Payne’s revenues have been in a downtrend from fiscal 2Q15 to fiscal 1Q16. In that period, its US Land Operations segment revenue declined 58%.
Company & Industry OverviewsHow Important Are Divestments to Shell’s Cash Flow?
Analyzing Shell’s cash flow In 2015, Royal Dutch Shell (RDS.A) generated around $30 billion in cash from operations. The company had cash outflows of $26 billion in the form of capital expenditure (capex) and $9 billion in the form of dividends, amounting to total cash outflows of $35 billion. To fund the gap of $5 […]
Company & Industry OverviewsChevron’s Leverage Position: Comfy or Cramped?
Chevron’s net debt-to-adjusted EBITDA stood at 1.4x in 4Q15. This is higher than the average ratio of 1.1x of Exxon Mobil, BP, and Royal Dutch Shell.
Company & Industry OverviewsWhy General Electric Sold Its Appliances Business to Haier
General Electric wants to shift away from the appliances business, as this segment doesn’t fit into its core business portfolio.
Company & Industry OverviewsWhy General Electric Aspires to be a Global Technology Leader in Energy Management
General Electric aspires to be a global technology leader in the transmission, distribution, and conversion of electrical power.
Company & Industry OverviewsWhat Sets General Electric Apart from Its Peers?
General Electric has had a presence in the S&P 500 (SPY) for more than two decades, which clearly illustrates its survival among competitors.
Macroeconomic AnalysisUS Steel Demand Indicators Have Been Mixed
Looking at steel demand indicators, we see that construction activity has generally been strong in 2015, with spending in the United States exceeding $1 trillion for seven consecutive months.
Earnings ReportIs Nucor Creating a War Chest for Acquisitions?
Nucor had a debt-to-capital ratio of 36% as of September 30, 2015. The company closed the quarter with cash and marketable securities of ~$2 billion.
Earnings ReportWhat Factors Drove Nucor’s 3Q15 Earnings?
Nucor’s capacity utilization rate fell to a dismal 69% in 3Q15. Nucor had a healthy utilization rate of 81% in 3Q14.
Earnings ReportSeagate’s Must-Know Strategy to Remain Competitive
In the previous part of this series, we saw that Seagate Technology’s (STX) lower-than-expected sales could give rival Western Digital (WDC) a competitive edge.
Financials Why dividend ETFs may be the right thing at the right time
Present-day U.S. stock markets seem to have fully recovered from the recessionary abyss. Markets are reaching peaks higher than pre-crisis levels, with major indices such as the S&P 500 (SPY), Dow Jones (DIA) and NASDAQ (QQQ) surging to record highs.
Financials Must-know: Dividends as a hedge against stock market bubbles
Dividends pay returns even during market recovery. Major market indices like the S&P 500 (SPY), Dow Jones (DIA) and NASDAQ (QQQ) can be seen surging to record highs during a bubble.
Energy & Utilities Why investors prefer dividends in a low interest rate environment
The Fed’s policy of keeping the nominal interest rates at a zero lower bound leads some investors to seek higher and stabler income elsewhere. The low-interest rate regime may force risk-taking investors towards the higher-cost debt of high yield bonds.
Healthcare Must-know: 3 key risks in stock market investing
Know the market and know your own appetite for risk before investing. You can’t eliminate market risk, also called systematic risk, through diversification. You can, however, hedge against market risk.